VeriMom¿Es ginsenoside rg4 seguro durante el embarazo?
No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
Related ingredients
Frequently asked questions
- ¿Es ginsenoside rg4 seguro durante el embarazo?
- No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
- ¿Es ginsenoside rg4 seguro durante la lactancia?
- No evidence was found that Rg4 is classified for reproductive or lactation hazard, and no studies showing transfer into milk or lactation toxicity for Rg4 were identified. By the priority rules, absence of CIR/SCCS/harmonised flags and lack of Rg4‑specific lactation data leads to default low hazard and mechanism scores. (Sources: PubChem/supplier pages; literature search on PubMed; EWG ingredient summary).
- ¿Es ginsenoside rg4 seguro para la piel del bebé?
- No infant‑specific toxicity data for Rg4 were identified. Dermal exposure assessment: Rg4 is a large, polar glycoside (MW ~767) typical of ginsenosides; such molecules have low dermal permeability, so adult topical exposure is likely negligible (e=0). However, given immature infant barrier and instruction in scoring, exposure for baby skin is increased by +1 to e=1 in absence of infant data. No infant dermal adverse effects or studies were found. (Sources: PubChem/supplier data on structure/MW; lack of reproductive/infant studies on PubMed; EWG ingredient page).
- ¿Cómo puntúa VeriMom a ginsenoside rg4?
- VeriMom puntúa ginsenoside rg4 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a ginsenoside rg4 en el embarazo?
- Consulta nuestra lista de alternativas seguras a ginsenoside rg4 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.